According to filings with the U.S. Securities and Exchange Commission, Atlas Oncology Holdings is raising up to $23,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Atlas Oncology Holdings
An embedded partner to oncologists, delivering whole-person care with compassion, innovation, and accountability. Atlas works with oncologists – not around them. We are fully embedded in clinical and virtual workflows, investing in the staff and technology needed to help practices thrive. We support patients across cancer types during active treatment, surveillance, and through end of life. The bond between patients and their oncologists is sacred and enduring. We build on that foundation to achieve industry-leading engagement, driving meaningful outcomes and measurable value. Atlas assumes full risk on medical spend, aligning incentives without disrupting existing network contracts or provider relationships.

To learn more about Atlas Oncology Holdings, visit https://www.atlasoncpartners.com/
Atlas Oncology Holdings Linkedin Page: https://www.linkedin.com/company/atlas-onc-partners/

Contact:
Kate Roberts, President
615-864-0524
https://www.linkedin.com/in/katherinebarnard/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.